Hoag is now enrolling patients in a clinical trial to study an innovative surgical procedure that would allow surgeons to repair a patient’s mitral valve without open-heart surgery. Known as the RESTORE clinical trial, the preeminent Orange County California hospital system joined Edwards Lifesciences, another Orange County-based organization, to evaluate the safety and effectiveness of the investigational product called HARPOON™ Beating Heart Mitral Valve Repair System for patients with severe degenerative mitral valve regurgitation, a condition triggered often by mitral valve prolapse.
Mitral valve prolapse, also known as click-murmur syndrome, Barlow’s syndrome, balloon mitral valve, or floppy valve syndrome, manifests as bulging of one or both of the mitral valve flaps (leaflets) into the left atrium during the contraction of the heart. For more details, follow the link to the description at the American Heart Association. This condition prevents the valve from closing properly and thus triggers blood to leak backward into the lungs leading to shortness of breath.
This prospective, multicenter non-randomized study (NCT04375332) is des...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).